NDC 68788-8654-06 - ZOLPIDEM TARTRATE
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 68788-8654
- Requested NDC
- 68788-8654-06
- Package NDCs from labels
- 68788-8654-3, 68788-8654-6, 68788-8654-9, 68788-8654-06
- Manufacturer
- Preferred Pharmaceuticals Inc.
- Effective date
- 2026-11-05
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| ZOLPIDEM TARTRATE - Preferred Pharmaceuticals Inc. | Preferred Pharmaceuticals Inc. | 2026-11-05 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68788-8654-3 | ZOLPIDEM TARTRATE | 30 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 30 | 2 | |
| 68788-8654-6 | ZOLPIDEM TARTRATE | 60 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 60 | 2 | |
| 68788-8654-9 | ZOLPIDEM TARTRATE | 90 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 90 | 2 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 68788-8654 | ZOLPIDEM TARTRATE TABLET, EXTENDED RELEASE [PREFERRED PHARMACEUTICALS INC.] | 1 | Current NDC, 3 package rows | 20240511_76ff87e4-3aa2-439d-8436-d9e6affb33c8.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 68788-8654-3 | EA - Each | 68788-8654 | 44adb2c3-0884-4f77-9844-97cabe62654d | 1 | 2024-06-10 |
| 68788-8654-6 | EA - Each | 68788-8654 | cf38b865-25d5-43e1-8fbf-417da1ac8b97 | 1 | 2024-06-10 |
| 68788-8654-9 | EA - Each | 68788-8654 | bf850e70-9810-47aa-9c2c-08477815a32d | 1 | 2024-06-10 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Zolpidem tartrate sublingual | ZOLPIDEM TARTRATE SUBLINGUAL | Par Health USA, LLC | 44b34e58-114b-4774-9fab-4b188dfe0228 | 2026-04-15 | Boxed warning, Warnings, Adverse reactions | WY6W63843K |
| ZOLPIDEM TARTRATE | ZOLPIDEM TARTRATE | The ACME Laboratories Ltd. | 5679ed64-8424-4e63-a3c9-91d80fff2ca6 | 2026-03-04 | Boxed warning, Warnings, Adverse reactions | WY6W63843K |
| ZOLPIDEM TARTRATE | ZOLPIDEM TARTRATE | NuCare Pharmaceuticals,Inc. | bca751bb-5161-5a95-e053-2a95a90aa2dd | 2026-02-19 | Boxed warning, Warnings, Adverse reactions | ANDA078970 854880 WY6W63843K |
| Zolpidem Tartrate | ZOLPIDEM TARTRATE | A-S Medication Solutions | 2556c804-7a5e-4dbd-aeef-a3ba3a247c39 | 2026-01-23 | Boxed warning, Warnings, Adverse reactions | WY6W63843K |
| Zolpidem Tartrate | ZOLPIDEM TARTRATE | A-S Medication Solutions | f67ef513-1b2c-42fe-bf33-4c7e9db191a3 | 2026-01-22 | Boxed warning, Warnings, Adverse reactions | WY6W63843K |
| ZOLPIDEM TARTRATE | ZOLPIDEM TARTRATE | Calvin Scott & Co., Inc. | 7da75d2b-905c-4fdf-bc53-1358c6477755 | 2026-01-15 | Boxed warning, Warnings, Adverse reactions | WY6W63843K |
| ZOLPIDEM TARTRATE | ZOLPIDEM TARTRATE | Direct_Rx | 907c7b18-2638-512c-e053-2995a90ae6fd | 2026-01-08 | Warnings, Adverse reactions | WY6W63843K |
| Zolpidem Tartrate | ZOLPIDEM TARTRATE | Northwind Health Company, LLC | 47212207-52a1-938b-e063-6294a90abca8 | 2025-12-29 | Boxed warning, Warnings, Adverse reactions | WY6W63843K |
| ZOLPIDEM TARTRATE | ZOLPIDEM TARTRATE | Northwind Health Company, LLC | 26e20f53-c042-eac0-e063-6394a90acfca | 2025-12-26 | Boxed warning, Warnings, Adverse reactions | WY6W63843K |
| ZOLPIDEM TARTRATE | ZOLPIDEM TARTRATE | Lupin Pharmaceuticals, Inc. | ac647afe-2fe5-4056-806f-abdd54789b45 | 2025-12-26 | Boxed warning, Warnings, Adverse reactions | ANDA078970 68180-779 854894 854880 e56668d7-16c2-4618-ba3b-df3853f307e6 ac647afe-2fe5-4056-806f-abdd54789b45 WY6W63843K |
| Zolpidem Tartrate | ZOLPIDEM TARTRATE | A-S Medication Solutions | 91511d2f-7066-49a0-90ea-2940d955c85e | 2025-11-26 | Boxed warning, Warnings, Adverse reactions | WY6W63843K |
| Zolpidem Tartrate | ZOLPIDEM TARTRATE | A-S Medication Solutions | ef72eb73-d058-4ca3-9013-691aae8426fb | 2025-11-26 | Boxed warning, Warnings, Adverse reactions | WY6W63843K |
| zolpidem tartrate | ZOLPIDEM TARTRATE | Golden State Medical Supply, Inc. | 41124767-8ff7-da5d-e063-6394a90a5203 | 2025-11-19 | Boxed warning, Warnings, Adverse reactions | 854894 854880 WY6W63843K |
| Zolpidem Tartrate | ZOLPIDEM TARTRATE | Bryant Ranch Prepack | 8425be72-2bbe-4090-b00e-610f1a1646b1 | 2025-11-19 | Boxed warning, Warnings, Adverse reactions | 854880 WY6W63843K |
| zolpidem tartrate | ZOLPIDEM TARTRATE | Almatica Pharma LLC | 2f1a3600-9bd6-3651-3ab5-1e4e0b0a3916 | 2025-10-09 | Boxed warning, Warnings, Adverse reactions | WY6W63843K |
| ZOLPIDEM TARTRATE | ZOLPIDEM TARTRATE | Preferred Pharmaceuticals, Inc. | a9ac3d4e-f502-41e3-95c0-0d334584566d | 2025-10-08 | Boxed warning, Warnings, Adverse reactions | WY6W63843K |
| ZOLPIDEM TARTRATE | ZOLPIDEM TARTRATE | Preferred Pharmaceuticals, Inc.. | 72e19b8e-d13a-4824-aee4-11778eba552c | 2025-10-08 | Boxed warning, Warnings, Adverse reactions | ANDA078970 854880 WY6W63843K |
| ZOLPIDEM TARTRATE | ZOLPIDEM TARTRATE | Bryant Ranch Prepack | 028bf425-7a72-464d-a242-aa5deee1ac23 | 2025-08-08 | Boxed warning, Warnings, Adverse reactions | ANDA078970 854894 WY6W63843K |
| Zolpidem Tartrate | ZOLPIDEM TARTRATE | ST. MARY'S MEDICAL PARK PHARMACY | 3bc8a122-aa21-212c-e063-6394a90a3bda | 2025-08-07 | Boxed warning, Warnings, Adverse reactions | WY6W63843K |
| Zolpidem Tartrate | ZOLPIDEM TARTRATE | Asclemed USA, Inc. | 9922ce14-b418-4235-9c59-d674a8e70210 | 2025-07-24 | Boxed warning, Warnings, Adverse reactions | WY6W63843K |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.